Revance Therapeutics shares owned by Barclays
Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Barclays
from 13F filings
Historical chart of Barclays investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by Barclays
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $3.1M | 358k | 8.79 |
| 2023-09-30 | $6.1M | 534k | 11.47 |
| 2023-06-30 | $7.1M | 281k | 25.31 |
| 2023-03-31 | $9.0M | 278k | 32.22 |
| 2022-12-31 | $5.7M | 309k | 18.46 |
| 2022-09-30 | $2.5M | 94k | 27.03 |
| 2022-06-30 | $625k | 45k | 13.82 |
| 2022-03-31 | $398k | 20k | 19.49 |
| 2021-12-31 | $1.8M | 109k | 16.32 |
| 2021-09-30 | $1.2M | 42k | 27.85 |
| 2021-06-30 | $809k | 27k | 29.64 |
| 2021-03-31 | $1.7M | 60k | 27.95 |
| 2020-12-31 | $805k | 28k | 28.33 |
| 2020-09-30 | $859k | 34k | 25.16 |
| 2020-06-30 | $886k | 36k | 24.42 |
| 2020-03-31 | $329k | 22k | 14.81 |
| 2019-12-31 | $896k | 55k | 16.22 |
| 2019-09-30 | $472k | 36k | 13.00 |
| 2019-06-30 | $538k | 42k | 12.96 |
| 2019-03-31 | $528k | 34k | 15.77 |
| 2018-12-31 | $326k | 16k | 20.11 |
| 2018-09-30 | $682k | 27k | 24.89 |
| 2018-06-30 | $341k | 12k | 27.45 |
| 2018-03-31 | $801k | 26k | 30.88 |
| 2017-12-31 | $684k | 19k | 35.72 |
| 2017-09-30 | $322k | 12k | 27.50 |
| 2017-06-30 | $0 | 11k | 0.00 |
| 2017-03-31 | $424k | 20k | 21.16 |
| 2016-12-31 | $169k | 8.1k | 20.87 |
| 2016-09-30 | $6.3k | 399 | 15.87 |
| 2016-06-30 | $47k | 3.4k | 13.66 |
| 2016-03-31 | $2.5k | 175 | 14.08 |
| 2015-12-31 | $14k | 453 | 30.00 |
| 2015-09-30 | $1.0M | 35k | 29.01 |
| 2015-06-30 | $14k | 380 | 37.04 |
| 2015-03-31 | $92k | 4.4k | 21.01 |
| 2014-12-31 | $8.0k | 491 | 16.29 |
| 2014-09-30 | $2.0k | 111 | 18.02 |
| 2014-06-30 | $67k | 2.0k | 33.98 |
| 2014-03-31 | $6.0k | 188 | 31.91 |